AGÕæÈ˹ٷ½

STOCK TITAN
  1. Home
  2. Sec-filings
  3. MNKD
  4. [Form 4] Mannkind Corporation Insider Trading Activity

[Form 4] Mannkind Corporation Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Negative)
Form Type
4

Filing content is currently unavailable.

Source:

Stock MNKD logo
Mannkind

NASDAQ:MNKD

MNKD Rankings

#2516 Ranked by Market Cap
N/A Ranked by Dividends

MNKD Latest News

Aug 27, 2025
MannKind to Present at Upcoming Investor Conferences
Aug 27, 2025
MannKind Announces Expansion of United Therapeutics Collaboration for Second Inhaled Therapy
Aug 25, 2025
MannKind to Acquire scPharmaceuticals, Accelerating Revenue Growth and Emerging as a Patient-Centric Leader in Cardiometabolic and Lung Diseases
Aug 6, 2025
MannKind and Blackstone Announce up to $500 Million Strategic Financing Agreement
Aug 6, 2025
MannKind Corporation Reports Second Quarter 2025 Financial Results And Provides Business Update

MNKD Latest SEC Filings

Aug 27, 2025
[8-K] Mannkind Corporation Reports Material Event
Aug 25, 2025
[SC TO-C] Mannkind Corporation Tender Offer Communication
Aug 25, 2025
[8-K] Mannkind Corporation Reports Material Event
Aug 6, 2025
[Form 4] Mannkind Corporation Insider Trading Activity
Aug 6, 2025
[10-Q] Mannkind Corporation Quarterly Earnings Report

MNKD Stock Data

1.20B
301.48M
1.66%
55.86%
7.74%
Biotechnology
Pharmaceutical Preparations
United States
DANBURY